Fundz

Navrogen, Inc.

CHEYNEY, PA · Biotechnology · 9 employees

Navrogen Inc. is a biopharmaceutical company focused on the targeted treatment of cancer. Navrogen is currently working on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells which inhibit the cancer-fighting humoral immune system.

Funding history

  • Funding Round — $542K — Jun 2024
  • Funding Round — $542K — Jun 2024
  • Funding Round — $9.1M — Feb 2023
  • Funding Round — $7.0M — Aug 2021
  • Series seed — $3.0M — Aug 2021

Recent signals

  • Jun 28, 2024: Raised $542K
  • Jun 27, 2024: Raised $542K
  • Feb 27, 2023: Raised $9.1M
  • Aug 12, 2021: Raised $7.0M
  • Aug 09, 2021: Raised $3.0M in Series seed
  • Sep 23, 2019: Raised $3.2M in Series seed
  • Oct 23, 2018: Raised $1.3M in Series seed

See plans & pricing → Track Navrogen, Inc.’s funding, hiring, and signals — with verified contacts — on Fundz.